Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
about
The Nrf2/HO-1 Axis in Cancer Cell Growth and ChemoresistanceNrf2 and Notch Signaling in Lung Cancer: Near the CrossroadDiscovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agentsLuteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cellsLuteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450.Integrated analysis identifies interaction patterns between small molecules and pathwaysDual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatmentLuteolin and Apigenin Attenuate 4-Hydroxy-2-Nonenal-Mediated Cell Death through Modulation of UPR, Nrf2-ARE and MAPK Pathways in PC12 Cells.The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical ApplicationLuteolin exerts an anticancer effect on NCI-H460 human non-small cell lung cancer cells through the induction of Sirt1-mediated apoptosis.Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet.Luteolin Impacts on the DNA Damage Pathway in Oral Squamous Cell Carcinoma.Differential expression patterns of Nqo1, AKR1B8 and Ho-1 in the liver and small intestine of C57BL/6 mice treated with sulforaphane.Cancer Prevention: Obstacles, Challenges and the Road Ahead.Inhibition of cancer antioxidant defense by natural compounds.Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1.Role of the Nrf2 signaling system in health and disease.Molecular targets of luteolin in cancerNrf2: a potential therapeutic target for naturally occurring anticancer drugs?Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastoma.Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS.Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.Luteolin reduces migration of human glioblastoma cell lines via inhibition of the p-IGF-1R/PI3K/AKT/mTOR signaling pathway.Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder.The regulatory G4 motif of the Kirsten ras (KRAS) gene is sensitive to guanine oxidation: implications on transcription.Docosahexaenoic acid-acylated phloridzin, a novel polyphenol fatty acid ester derivative, is cytotoxic to breast cancer cells.Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells.Keap1-Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics.Inducers of Senescence, Toxic Compounds, and Senolytics: The Multiple Faces of Nrf2-Activating Phytochemicals in Cancer Adjuvant Therapy.
P2860
Q26772298-F6E22273-E867-455E-AFD6-B3FC1FD9E1FEQ28066915-FE3165FF-0402-4E7F-8444-C1D1350A361DQ28085561-CAE3F148-9D52-4CCB-8991-3E2D37709AE7Q33599474-28903564-EBE3-4F99-A1C6-552C2ADF29CAQ33689090-091E9EED-F592-43DF-B8C4-7BA43C93D208Q33999789-6258008A-654F-480A-93B2-F8AC506B921AQ35118710-0FA98DDE-F16F-43F6-8819-B07AF706454CQ35667423-7D12AAF7-B224-47FB-B466-8A0194127CF8Q35726483-AB371A79-332D-47CA-B72B-BE73BB078E90Q35806779-8E88E734-E6ED-4351-AB33-694F604E52A7Q35919748-A422B080-F18D-4244-BDE1-D4BAD7726F67Q35925853-5D6C3D59-D730-4D87-86E6-290C7D118713Q36042031-310BBE22-2E57-43C9-85A0-C9346150A53AQ36637024-BFAE5AB7-1F54-4FF9-A1DF-A991DAB45917Q37002946-85468106-C20C-4E0C-B157-15F7790F6CD0Q37716657-5DD82367-F0DC-4A1A-AE5E-F29495C0287DQ37745238-3094EBCA-2A21-401B-95A5-D5E618000231Q38237494-B8D61B30-1D58-4B6C-B1DE-62D82197B254Q38365120-381264B6-E051-4489-B8C6-416D965D83C2Q38694717-C201F888-C14F-49A3-85CF-BA04235DF17CQ38708291-E82F7D63-C84A-44D4-AC50-C67AE2BF901FQ38755306-4F34EDD4-7EBA-47FD-9A89-A3016CF274F4Q38881066-0E0A6D00-A68E-4BBF-913E-CD5919CF6CC3Q41615594-2C4936A6-8A2D-4BB8-8550-4C046AD1072EQ42265341-76E52528-6850-4C45-972F-5D1800B88C86Q47373966-4F4E0C7A-E2D1-4D5B-AD26-494DCC118F7AQ50221472-0BA88079-00DD-4658-8F15-09F987D38D1AQ50893739-6725BD38-9B74-48F2-8793-482923CF13BEQ50921781-7E4A11EC-2C47-43C3-B05A-19777D45B4D1Q52331716-E085EF45-FE9E-4906-A201-A8A317181CBA
P2860
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
@en
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
@nl
type
label
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
@en
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
@nl
prefLabel
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
@en
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
@nl
P2093
P1476
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
@en
P2093
Ruby Thapa
Song Chian
Xiu Jun Wang
P304
P356
10.1016/J.BBRC.2014.04.039
P407
P50
P577
2014-04-18T00:00:00Z